Evidence map›Paper›PMID 32100557›Full record

ArticleCirculation2020

Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction.

Tim Christian Kuhn, Johannes Knobel, Sonja Burkert-Rettenmaier, Xue Li, Ingmar Sören Meyer, Andreas Jungmann, Florian Sicklinger, Johannes Backs, Felix Lasitschka, Oliver J Müller and 3 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Interstitial cells and arrhythmia.American journal of physiology. Cell physiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  14. Cyanidin prevents cardiomyocyte apoptosis in mice after myocardial infarction.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  15. SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Enhanced fibrotic potential of COL1A1Frontiers in cardiovascular medicine · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Tim Christian KuhnDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Johannes KnobelDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Sonja Burkert-RettenmaierDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Xue LiDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Ingmar Sören MeyerDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Andreas JungmannDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Florian SicklingerDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Johannes BacksDZHK (German Centre for Cardiovascular Research), Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., J.B., H.A.K., F.L.).
Felix LasitschkaInstitute of Pathology, University of Heidelberg, Germany (Fe.L.).
Oliver J MüllerDepartment of Internal Medicine III, University of Kiel, Germany (O.J.M.).
Hugo A KatusDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Jeroen KrijgsveldDeutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany (Je.K.).
Florian LeuschnerDepartment of Cardiology, Medical University Hospital, Heidelberg, Germany (T.C.K., J.K., S.B-R., X.L., I.S.M., A.J., F.S., H.A.K., F.L.).
Heidelberg University · DEHochschule für Angewandte Wissenschaften Kiel · DEMedigene (Germany) · DESanta Fe Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute occlusion of a coronary artery results in swift tissue necrosis. Bordering areas of the infarcted myocardium can also experience impaired blood supply and reduced oxygen delivery, leading to altered metabolic and mechanical processes. Although transcriptional changes in hypoxic cardiomyocytes are well studied, little is known about the proteins that are actively secreted from these cells.

methodsWe established a novel secretome analysis of cardiomyocytes by combining stable isotope labeling and click chemistry with subsequent mass spectrometry analysis. Further functional validation experiments included ELISA measurement of human samples, murine left anterior descending coronary artery ligation, and adeno-associated virus 9-mediated in vivo overexpression in mice.

resultsThe presented approach is feasible for analysis of the secretome of primary cardiomyocytes without serum starvation. A total of 1026 proteins were identified to be secreted within 24 hours, indicating a 5-fold increase in detection compared with former approaches. Among them, a variety of proteins have not yet been explored in the context of cardiovascular pathologies. One of the secreted factors most strongly upregulated upon hypoxia was PCSK6 (proprotein convertase subtilisin/kexin type 6). Validation experiments revealed an increase of PCSK6 on mRNA and protein level in hypoxic cardiomyocytes. PCSK6 expression was elevated in hearts of mice after 3 days of ligation of the left anterior descending artery, a finding confirmed by immunohistochemistry. ELISA measurements in human serum also indicate distinct kinetics for PCSK6 in patients with acute myocardial infarction, with a peak on postinfarction day 3. Transfer of PCSK6-depleted cardiomyocyte secretome resulted in decreased expression of collagen I and III in fibroblasts compared with control treated cells, and small interfering RNA-mediated knockdown of PCSK6 in cardiomyocytes impacted transforming growth factor-β activation and SMAD3 (mothers against decapentaplegic homolog 3) translocation in fibroblasts. An adeno-associated virus 9-mediated, cardiomyocyte-specific overexpression of PCSK6 in mice resulted in increased collagen expression and cardiac fibrosis, as well as decreased left ventricular function, after myocardial infarction.

conclusionsA novel mass spectrometry-based approach allows investigation of the secretome of primary cardiomyocytes. Analysis of hypoxia-induced secretion led to the identification of PCSK6 as being crucially involved in cardiac remodeling after acute myocardial infarction.

Indexed as

Ventricular Function, LeftVentricular RemodelingAnimalsAnimals, NewbornCells, CulturedDisease Models, AnimalHumansMaleMice, Inbred C57BLMyocardial InfarctionMyocytes, CardiacProprotein Convertase 9ProteomeRats, WistarSecretory PathwaySignal TransductionPCSK9 protein, humanPcsk9 protein, mousePCSK9 protein, ratProprotein Convertase 9Proteomecardiac remodeling, atrialcardiac remodeling, ventricularcardiomyocytesmyocardial infarctionproteomes

Identifiers

PMID32100557
OpenAlexW3006725491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.